Avadel Pharmaceuticals Announces $65 Million Private Placement with Leading Biotech Investment Funds
DUBLIN, Ireland, Feb. 21, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, […]